Facial rejuvenation market

Facial Rejuvenation Market, by Product Type (Topical Rejuvenation Products (Keratolytics, Moisturizers, Retinoids, Sunscreens, Hair Removals) Botulinum products, Dermal Fillers (Absorbable Dermal Fillers, Non Absorbable Dermal Fillers), Chemical Peels, Micro Abrasion, Equipment’s (Laser Based Equipment’s, Ultrasound Based Equipment’s), by End User (Hospitals, Dermatology Clinics and Beauty Centers and Spa ), and by Regions (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030

Request Free Sample

Sep 2022
CMI3189
190 Pages
Excel & Pdf
Medical Devices

Summary

Facelifts, sometimes referred to as rhytidectomy, are occasionally necessary to treat sagging face skin. A facelift can be achieved using a variety of ways. Eyelid rejuvenation can be done concurrently with or before a face and neck lift.

Global facial rejuvenation market is estimated to be valued at US$ 24,616.7 million in 2022 and is expected to exhibit a CAGR of 7.7 % during the forecast period (2022-2030).

Figure 1. Global Facial Rejuvenation Market Share (%), by Region, 2022

Increasing product launch and approvals for facial rejuvenation are expected to drive growth of the facial rejuvenation market.

Increasing product launch and approvals for facial rejuvenation are expected to drive growth of the facial rejuvenation market. For instance, in May 2022, The U.S. Food and Drug Administration (FDA) approved the Renuvion Dermal Handpiece for the treatment of moderate to severe wrinkles and rhytides, limited to patients with fitzpatrick skin types.

Figure 2. Global Facial Rejuvenation Market Share (%), by End User, 2022

Increasing approvals of technologically advancement are expected to drive market growth during the forecast period.

Increasing approvals of technologically advancement are expected to drive market growth during the forecast period. For instance, in April 2021, Alma, one of the global leaders of energy-based medical and aesthetics solutions, launched Alma PrimeXTM device, for skin tightening.

Report Coverage

Report Coverage	Details
Base Year:	2021	Market Size in 2022:	US$ 24,616.7 Mn
Historical Data for:	2017 to 2020	Forecast Period:	2022 to 2030
Forecast Period 2022 to 2030 CAGR:	7.7 %	2030 Value Projection:	US$ 44,547.1 Mn
Geographies covered:	North America: U.S. and Canada Latin America: Brazil, Argentina, Mexico, and Rest of Latin America Europe: Germany, U.K., Spain, France, Italy, Russia, and Rest of Europe Asia Pacific: China, India, Japan, Australia, South Korea, ASEAN, and Rest of Asia Pacific Middle East: GCC Countries, Israel, and Rest of Middle East Africa: South Africa, North Africa, and Central Africa
Segments covered:	By Product Type: Topical Rejuvenation Products (Keratolytics, Moisturizers, Retinoids, Sunscreens, Hair Removals), Botulinum products, Dermal Fillers (Absorbable Dermal Fillers, Non Absorbable Dermal Fillers), Chemical Peels, Micro Abrasion, Equipment’s, Laser Based Equipment’s, Ultrasound Based Equipment’s By End User: Hospitals, Dermatology Clinics, Beauty Centers and Spa
Companies covered:	Merz Pharma, Anika Therapeutic, Lumenis, Galderma, Allergan (Actavis), Contura Ltd, Fibrocell ScienceInc., Revance Therapeutics, Cynosure, Bausch Health Companies Inc., Alma Lasers ,STRATA Skin Sciences, LUTRONIC ,Sciton, Inc.
Growth Drivers:	Increasing product launch and approvals for facial rejuvenation Increasing approvals of technologically advancement
Restraints & Challenges:	High cost of facial rejuvenation procedures

Global Facial Rejuvenation Market– Impact of Coronavirus (COVID-19) Pandemic

Since the COVID-19 virus outbreak in December 2019, the disease has spread to over 100 countries across the globe and the World Health Organization had declared it a public health emergency on January 30, 2020.

COVID-19 has affected the economy in three main ways: by directly affecting production and demand of drugs and vaccines, by creating disruptions in distribution channels, and through its financial impact on firms and financial markets. Due to nationwide lockdowns, several countries, such as China, India, Saudi Arabia, U.A.E., Egypt, and others, faced problems with regard to the transportation of drugs and vaccines, etc. from one place to another.

However, the COVID-19 pandemic had a positive impact on the global facial rejuvenation market. During the pandemic, 11% of women surveyed in U.S. indicated they are more interested in cosmetic surgery or non-surgical procedures now than before COVID-19, and the figure is even higher among women who have already had surgery or a procedure – 24%, respectively. Moreover, 35% of women who have previously had at least one cosmetic surgical procedure or minimally invasive procedure plan to spend significantly or somewhat more on treatments in 2021 than in 2020.

Global Facial Rejuvenation Market: Key Developments

Key players in the market are focused on establishing subsidiaries to expand their geographical presence. For instance, in October 2019, InMode Ltd. which is global provider of innovative, radiofrequency minimally and non-invasive medical technology, completed the establishment of two new subsidiaries in Asia Pacific - InMode India and InMode Australia.

In December 2019, Daewoong Pharmaceutical, a pharmaceutical company based in South Korea, received approval for its botulinum toxin product, Nabota, from The Ministry of Health in the U.A.E. and Indonesia’s Badan Pengawas Obat dan Makanan.

Global Facial Rejuvenation Market: Restraint

The major factors that hinder growth of the global facial rejuvenation market include high cost of facial rejuvenation procedures. For instance, according to American Society of Plastic Surgeons (ASPS), the average cost of intense pulsed light (IPL) treatment is US$ 412 and the average cost of nonsurgical skin tightening is US$ 2,456.

Key Players

Major players operating in the global facial rejuvenation market include Merz Pharma, Anika Therapeutic, Lumenis, Galderma, Allergan (Actavis), Contura Ltd,Fibrocell ScienceInc., Revance Therapeutics, Cynosure, Lumenis, Bausch Health Companies Inc., Alma Lasers ,STRATA Skin Sciences, LUTRONIC ,Sciton, Inc.

Table of Content

Table of Contents

*Browse 27 market data tables and 31 figures on “Global Facial Rejuvenation Market” - Global forecast to 2030

Segmentation

Detailed Segmentation:

- Frequently Asked Questions -

What is the current market size and compound annual growth rate (CAGR) of the global facial rejuvenation market during the forecast period (2022-2030)?

Global facial rejuvenation market size is estimated to be valued at US$ 24,616.7 million in 2022 and is expected to exhibit a CAGR of 7.7 % between 2022 and 2030.

What are the major factors driving the market growth?

Factors such as increasing product launch and approvals for facial rejuvenation and increasing geriatric population are major factors driving the market.

Which is the leading region segment in the market?

North America is the leading application segment in the market.

What are the key factors hampering growth of the market?

The major factors hampering growth of the global facial rejuvenation market include high cost of facial rejuvenation procedures.

Which are the major players operating in the market?

Major players operating in the market include Merz Pharma, Anika Therapeutic, Lumenis, Galderma, Allergan (Actavis), Contura Ltd,Fibrocell ScienceInc., Revance Therapeutics, Cynosure, Bausch Health Companies Inc., Alma Lasers ,STRATA Skin Sciences, LUTRONIC ,Sciton, Inc.